Sibley D R, Creese I
Endocrinology. 1980 Nov;107(5):1405-9. doi: 10.1210/endo-107-5-1405.
[3H]Spiroperidol ([3H]SPIRO) and [3H]N-n-propylnorapomorphine ([3H]NPA), a dopamine antagonist and agonist, respectively, were found to bind stereospecifically to bovine intermediate lobe pituitary membranes. The specific binding was saturable ([3H]SPIRO maximum number of binding sites, 11.2 pmol/g tissue; [3H]NPA maximum number of binding sites, 5.0 pmol/g tissue) and of high affinity affinity ([3H]SPIRO dissociation constant, 0.17 nM; [3H]NPA dissociation constant, 0.35 nM). The rank order of catecholamines, phenothiazines, and related drugs in competing for [3H]SPIRO and [3H]NPA binding is consistent with interactions at a dopamine receptor. Guanine nucleotides were found to selectively decrease agonist but not antagonist affinities for these binding sites. With the addition of 0.1 mM GTP, the ability of agonists to displace [3H]SPIRO binding is decreased 5- to 7-fold, while the dissociation constant for [3H]NPA is increased to 0.8 nM.
[3H]螺哌啶醇([3H]SPIRO)和[3H]N-正丙基去甲阿扑吗啡([3H]NPA),分别为多巴胺拮抗剂和激动剂,被发现能立体特异性地结合牛垂体中间叶膜。特异性结合是可饱和的([3H]SPIRO的最大结合位点数为11.2 pmol/g组织;[3H]NPA的最大结合位点数为5.0 pmol/g组织)且具有高亲和力([3H]SPIRO的解离常数为0.17 nM;[3H]NPA的解离常数为0.35 nM)。儿茶酚胺、吩噻嗪及相关药物在竞争[3H]SPIRO和[3H]NPA结合时的排序与多巴胺受体上的相互作用一致。发现鸟嘌呤核苷酸能选择性降低激动剂但不降低拮抗剂对这些结合位点的亲和力。加入0.1 mM GTP后,激动剂取代[3H]SPIRO结合的能力降低5至7倍,而[3H]NPA的解离常数增加至0.8 nM。